STENTiT Enrolls First Patient in Trial of Regenerative Stent for Limb Preservation
STENTiT, a pioneering medical device company, developing a novel class of stents with regenerative properties, has announced the successful implantation of its Resorbable Fibrillated Scaffold (RFS). As part of the VITAL-IT 1 study, patients with chronic limb-threatening ischemia (CLTI) below-the-knee, have successfully been treated using the RFS implant. In this
